Riskpilot← Back to searchSign inGet full accessKLINIKK A AS
ASActiveOrg 926594338Enebakkveien 150, 0680 OsloMedical specialists activities · NACE 8622Est. 20215 employees
Revenue 2024
NOK 11,7M
+60% vs 2023
EBITDA margin
-8.0%
+68% vs 2023
Equity ratio
-838.3%
Financial strength
Net profit 2024
NOK -991K
+66% vs 2023
| Revenue | NOK 11,7M | +60% |
| EBITDA | NOK -934K | +68% |
| Net profit | NOK -991K | +66% |
| Total assets | NOK 983K | +11% |
| Equity | NOK -8,2M | -14% |
| Employees | 5 | — |
Legal name
KLINIKK A AS
Org number
926594338
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. februar 2021
Share capital
NOK 1 000 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Medisinsk kirurgi og rådgivning samt det som naturlig står i forbindelse med dette.
Address
Enebakkveien 150, 0680 Oslo
Phone
+4722382020
Email
post@klinikk-a.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 929 | 5 089 | 7 304 | 11 655 |
| Staff expenses | −1 917 | −1 992 | −1 149 | −1 685 |
| EBITDA | −2 679 | −2 623 | −2 896 | −934 |
| Depreciation & amort. | −5 | −13 | −13 | −13 |
| EBIT | −2 684 | −2 636 | −2 909 | −947 |
| Net financials | −1 | −2 | −9 | −44 |
| Profit before tax | −2 685 | −2 638 | −2 918 | −991 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −2 685 | −2 638 | −2 918 | −991 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 095 | 528 | 884 | 983 |
| Equity | −1 690 | −4 328 | −7 246 | −8 237 |
| Long-term debt | 0 | 250 | 375 | 825 |
| Short-term debt | 2 785 | 4 606 | 7 755 | 8 395 |
| Total debt | 2 785 | 4 856 | 8 130 | 9 220 |
EBITDA margin
-8.0%
This company
15.8%
Market median
-151% vs market
20212024
Equity ratio
-838.3%
This company
38.2%
Market median
-2295% vs market
20212024
Return on equity
-99103600.0%
This company
18.4%
Market median
-538606622% vs market
20212024
Net profit margin
-8.5%
This company
8.1%
Market median
-205% vs market
20212024
Asset turnover
11.86×
This company
1.12×
Market median
+959% vs market
20212024
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-13 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SB Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40% | 40% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLINIKK A AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ståle Buhagen | Chief Executive Officer | 0 companies |
| Bjørn Wahl | Chairman | 0 companies |
| Vibeke Andrea Stanford | Board of Directors | 0 companies |
| Aage Alexander Wahl | Chairman | 0 companies |
| Petter Frode Amland | Board of Directors | 0 companies |